Who
Linda West
Director
Company insider
Files Form 4 as: Director, Context Therapeutics; Director, Galera Therapeutics.
In numbers
- Trades disclosed
- 18
- Buys
- 5
- Sells
- 0
- Bought
- $405K
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 31 Mar 2020
- Last trade
- 24 Jun 2026
- Last filed
- 26 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Jun 2026filed 26 Jun 2026 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 24 Jun 2026filed 26 Jun 2026 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
| 12 Jun 2025filed 12 Jun 2025 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —123,500 at $0.00 | filing |
| 13 Jun 2024filed 14 Jun 2024 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Jul 2023filed 5 Jul 2023 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —23,382 at $0.00 | filing |
| 14 Jun 2023filed 16 Jun 2023 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —48,000 at $0.00 | filing |
| 31 May 2023filed 31 May 2023 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 1 Jul 2022filed 5 Jul 2022 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —58,496 at $0.00 | filing |
| 15 Jun 2022filed 16 Jun 2022 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 2 Jun 2022filed 3 Jun 2022 | CNTX Context Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 17 Dec 2021filed 20 Dec 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $55K20,000 at $2.74 | filing |
| 1 Jul 2021filed 6 Jul 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,730 at $0.00 | filing |
| 16 Jun 2021filed 17 Jun 2021 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —9,888 at $0.00 | filing |
| 15 Jun 2021filed 17 Jun 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $91K10,000 at $9.13 | filing |
| 2 Jun 2021filed 4 Jun 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $87K10,000 at $8.65 | filing |
| 1 Jun 2021filed 2 Jun 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $86K10,000 at $8.64 | filing |
| 28 May 2021filed 2 Jun 2021 | Galera TherapeuticsBiotechnology | SEC FORM 4 Bought | $86K10,000 at $8.64 | filing |
| 31 Mar 2020filed 2 Apr 2020 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —19,776 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.